We know that every day America’s hospitals and health systems—and other health care providers—are faced with the daunting task of complying with a growing number of federal regulations.
 
Make no mistake about it—we understand the need for “responsible” regulation—that ensures public accountability in meeting the highest standards of care … and improves the beneficiary experience.
 
At the same time, hospitals are constantly challenged to understand and implement new or revised regulations—all while keeping track of the old ones—and doing so as they meet and maintain their core mission of providing high-quality services.
 
There is growing frustration about the amount of time and resources being devoted to pushing paper—or its electronic version—versus spending time on care.
 
The bottom line: patients have less time with their caregivers; they have unnecessary hurdles in receiving care; and the regulatory burden increases health care costs.
 
Last October the Centers for Medicare & Medicaid Services announced a regulatory relief initiative in which we are pleased to be a partner.
 
This week we had the opportunity to host CMS Administrator Seema Verma for a special AHA Town Hall Webcast focused on the regulatory landscape and the work CMS is considering that could provide regulatory relief to hospitals and health systems. We appreciate CMS’s focus on reducing the regulatory burden and the leadership Ms. Verma has already provided in this arena.
 
Among other topics, she stated her commitment for CMS to support a transition from a fee-for-service system to one that favors value and outcomes—a goal we at the AHA strongly share. She also shared with us her plans for innovation around payment reform, including accountable care organizations. In addition, we discussed the barriers to implementation of new payment models posed by outdated rules such as the Stark law.
 
We look forward to working with CMS to ensure that we have more responsible and reasonable regulations—ones that reflect the realities that doctors and nurses face on the front lines—to enable them to provide care in an efficient and effective manner.
 
Please stay tuned for more developments on this front from us in the future.
 
 

Related News Articles

Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate…
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law…
Headline
The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models. “The 340B…
Headline
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
The AHA May 8 filed an amicus brief in the U.S. District Court for the District of Nebraska in defense of the state’s 340B contract pharmacy law prohibiting…
Headline
The Trump administration May 5 issued two executive orders on pharmaceutical manufacturing and life-sciences research. The first executive order, "…